-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
BEIJING, Aug. 23 (Xinhua Liu Xia) British scientists in the latest issue of the journal Nature Medicine, they analyzed blood samples of 63 patients with neo-coronary pneumonia, in the patient's blood concentration abnormality of several molecules, found a predictable future severity of the patient's three molecules: IP-10, white melebin 10 and white melebin, the latest research can help to better manage patients.
Xinhua) -- Researchers from the Francis Crick Institute, King's College London and others say their latest study found that patients with neo-coronary pneumonia, who have significantly higher concentrations of these molecules in their blood when admitted to hospital for the first time, are more likely to develop the condition later.
these three molecules are a strict predictor of disease severity compared to common clinical indicators including C-reactive protein (CRP), D-djumer, or ferrine.
, they also found that measuring the concentration of IP-10 in the blood of patients with neo-coronary pneumonia on the first day of hospitalization was by far the most accurate way to predict how long patients would be hospitalized.
researchers are currently looking for collaborators to help develop reliable and convenient detection methods for these molecules.
, director of the New Coronary Project, said: "The new crown pneumonia is still raging, the flu may be coming soon and hospitals will be under a lot of pressure.
to solve this problem, we need to equip doctors with tools to help them make informed judgments about which patients may be better off and which patients may need more urgent care to better manage patients."
May this year, the team compared the immune characteristics of patients with neo-crown pneumonia with 10 patients of the same age who developed lower respiratory tract infections with non-neo-crown pneumonia.
found that no high concentrations of these three molecules were found in the latter, suggesting that the feature, along with other features, may have formed an immune characteristic at the core of neo-coronary pneumonia.
.